Trials
Browse registered studies, linked candidates, conditions, and sponsors.
Trials6597registered studies
With drugs6596linked candidates
With diseases6597linked conditions
With sponsors6122organisations loaded
Status mix
Full catalog
Phase mix
Full catalog
Starts by year
From 2000
Trial catalog
Search by registry ID, title, or sponsor.
| Trial ID | Title | Phase | Status | Enrollment | Lead sponsor |
|---|---|---|---|---|---|
| NCT07229339 | Phase 2 Trial of Zipalertinib in Patients With Resectable Non-Small Cell Lung Cancer With EGFR Exon 20 Insert… | PHASE2 | Not yet recruiting | 16 | Jonsson Comprehensive Cancer Center |
| NCT04266730 | Phase I Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Administered Concurrently With … | PHASE1 | Terminated | 6 | UNC Lineberger Comprehensive Cancer Center |
| NCT07450183 | Phase II Trial of Perioperative Cemiplimab in Patients With Resectable Non-small Cell Lung Cancer and PD-L1 ≥… | PHASE2 | Not yet recruiting | 33 | Henry Ford Health System |
| NCT07603856 | A Randomized Phase II Study of Radiotherapy Plus Immune Checkpoint Inhibitor Therapy Versus Standard of Care … | PHASE2 | Active | 39 | University of Chicago |
| NCT07234877 | A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemo… | PHASE2 | Not yet recruiting | 158 | European Organisation for Research and Treatment of Cancer - EORTC |
| NCT07247786 | Phase II Randomized Clinical Trial for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant (… | PHASE2 | Not yet recruiting | 68 | Fundación GECP |
| NCT07504588 | A Randomized Phase II Trial of Sacituzumab Govitecan (SG) and Bevacizumab Versus Standard of Care Carboplatin… | PHASE2 | Not yet recruiting | 87 | National Cancer Institute (NCI) |
| NCT07322341 | A Phase 2 Trial of SX-682 and Atezolizumab in Patients With Advanced NSCLC Who Progressed on Prior Chemothera… | PHASE2 | Not yet recruiting | 32 | University of Washington |
| NCT07541170 | A Phase III, Randomized, Open-label Study Evaluating the Efficacy and Safety of Divarasib Compared With Inves… | PHASE3 | Not yet recruiting | 400 | Hoffmann-La Roche |
| NCT07543172 | Phase II Study of CIMAVAX-EGF in Combination With KRAS G12C Inhibitors as Treatment for Advanced Stage KRAS G… | PHASE2 | Not yet recruiting | 29 | Roswell Park Cancer Institute |
| NCT07146230 | The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2) | PHASE2 | Not yet recruiting | 52 | Montefiore Medical Center |
| NCT07135882 | A Randomised Phase III Trial of Up-front Radiotherapy Before Standard-of-care Systemic Therapy in Advanced Lu… | PHASE3 | Not yet recruiting | 420 | Trans Tasman Radiation Oncology Group |
| NCT06943664 | Phase II Trial: Photoimmunotherapy and Anti-PD1 in Patients With Refractory Inoperable and Metastatic Non-Sma… | PHASE2 | Not yet recruiting | 27 | Roswell Park Cancer Institute |
| NCT07393555 | A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and I… | PHASE2 | Not yet recruiting | 117 | SWOG Cancer Research Network |
| NCT05642195 | Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-A… | PHASE1/PHASE2 | Terminated | 30 | National Cancer Institute (NCI) |
| NCT06694454 | Phase I/II Study of Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736… | PHASE1/PHASE2 | Active | 60 | National Cancer Institute (NCI) |
| NCT06449313 | A Phase 2 Single-Arm Study of Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advance Non-S… | PHASE2 | Active | 21 | Georgetown University |
| NCT07149649 | Magnesium Supplementation in Addition to Standard Chemo-immunotherapy in Patients With Locally Advanced Unres… | PHASE2/PHASE3 | Active | 230 | Swiss Cancer Institute |
| NCT07265739 | A Phase 2 Study of Losartan in Combination With Weekly Paclitaxel in Platinum Resistant Ovarian Cancer | PHASE2 | Not yet recruiting | 27 | Massachusetts General Hospital |
| NCT07551778 | An Exploratory Clinical Study to Evaluate the Safety and Efficacy of Allogeneic NK Cell Injection Combined Wi… | PHASE1/PHASE2 | Not yet recruiting | 20 | BOE Technology Group Co., Ltd. |
| NCT07360743 | Anti-PD1 Monotherapy in 1L Advanced NSCLC Patients With PD-L1 TPS > 50% and PTI=0 | PHASE2 | Not yet recruiting | 275 | UNICANCER |
| NCT07586202 | A Phase 2 Study Evaluating the Safety and Efficacy of Neoadjuvant Amivantamab in Combination With Lazertinib … | PHASE2 | Active | 68 | Janssen Research & Development, LLC |
| NCT07293247 | Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-PORT) for Resected Non-Small Cell … | PHASE2 | Active | 164 | Alliance for Clinical Trials in Oncology |
| NCT07355205 | A Phase II, Single-Center, Open-Label Study of First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inb… | PHASE2 | Active | 26 | Washington University School of Medicine |
| NCT07382726 | Combination Of Izalontamab Brengitecan And Adagrasib In Advanced KRAS G12Ci-Refractory Non-Small Cell Lung Ca… | PHASE1 | Not yet recruiting | 18 | M.D. Anderson Cancer Center |